NCT03870737View on ClinicalTrials.gov

Four-week Open-trial Extension TNS for ADHD

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DEVICE

Active TNS

Participants will receive 4-weeks nightly treatment with active TNS. Positive responders will be invited to participate in 12-month open-extension study.

Trial Locations (1)

90095

UCLA Semel Institute, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of California, Los Angeles

OTHER

NCT03870737 - Four-week Open-trial Extension TNS for ADHD | Biotech Hunter | Biotech Hunter